Iran breaks German monopoly in type 2 diabetes drug

Iran breaks German monopoly in type 2 diabetes drug

Iran breaks German monopoly in type 2 diabetes drug

 

 
Sales manager of Abidi Pharmaceutical Co. Reihaneh Rouhani, while pointing to the unveiling process of Sitagliptin with brand name Ziptin to treat type 2 diabetes, said Iran could break the monopoly of Ziptin drug already produced by a German Co.

اخبار مرتبط

Iran welcomes human rights dialogue with EU

Deputy FM: Iran acting on JCPOA commitments

Headlines in Iranian English-language dailies on April 18

0 نظر

ارسال نظر

capcha